SCHEMBL16628673

SCHEMBL16628673

NC(O)=S.OC(=S)N(c1cccc2c1ccc1ccccc12)c1cccc2c1ccc1ccccc12.[KH]

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPRT1 P00492 3/20 0.44
SIGMAR1 Q99720 4/20 0.43
PTPN1 P18031 2/20 0.38
ALDH1A1 P00352 5/20 0.38
TDP1 Q9NUW8 2/20 0.38
CYP2A6 P11509 1/20 0.38
TSHR P16473 1/20 0.38
HSD17B10 Q99714 1/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
KDM4E B2RXH2 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
ALOX12 P18054 1/20 0.37
CYP2C19 P33261 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.36
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16628462 0.98 HPRT1 (0.45) HPRT1SIGMAR1PTPN1ALDH1A1TDP1
SCHEMBL16628384 0.97 HPRT1 (0.44) HPRT1SIGMAR1PTPN1ALDH1A1TDP1
SCHEMBL3069182 0.83 SIGMAR1 (0.53) SIGMAR1PTPN1ALDH1A1TDP1CYP2A6
SCHEMBL16628392 0.80 HPRT1 (0.42) HPRT1SIGMAR1PTPN1ALDH1A1TDP1
SCHEMBL16628402 0.80 HPRT1 (0.42) HPRT1SIGMAR1PTPN1ALDH1A1TDP1
SCHEMBL16628639 0.79 ALDH1A1 (0.47) SIGMAR1PTPN1ALDH1A1HSD17B10MEN1
SCHEMBL16628459 0.79 HPRT1 (0.48) HPRT1SIGMAR1ALDH1A1TDP1CYP2A6
Potassium Ion SCHEMBL16628672 0.78 HPRT1 (0.47) HPRT1SIGMAR1PTPN1ALDH1A1TDP1
SCHEMBL16628391 0.78 HPRT1 (0.47) HPRT1SIGMAR1PTPN1ALDH1A1TDP1
SCHEMBL16628399 0.78 HPRT1 (0.47) HPRT1SIGMAR1ALDH1A1TDP1CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2860170-B1 PROCESS FOR PREPARING 4-HYDROXYBUTYL ACRYLATE OSAKA ORGANIC CHEMICAL IND LTD (JP) 2019-08-28 EP disclosed
US-9670129-B2 Process for preparing 4-hydroxybutyl acrylate OSAKA ORGANIC CHEMICAL INDUSTRY LTD. (JP) 2017-06-06 US disclosed
US-20150126766-A1 PROCESS FOR PREPARING 4-HYDROXYBUTYL ACRYLATE OSAKA ORGANIC CHEMICAL INDUSTRY LTD. (JP) 2015-05-07 US disclosed
EP-2860170-A1 PROCESS FOR PREPARING 4-HYDROXYBUTYL ACRYLATE Osaka Organic Chemical Ind., Ltd. (JP) 2015-04-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150126766-A1 PROCESS FOR PREPARING 4-HYDROXYBUTYL ACRYLATE LTB4R2, LTA4H, LTB4R HPRT1 2025/4885SIGMAR1 3189/4885PTPN1 4118/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.